Want to see CTVA full AI Analyst Report?
CTVA Stock Chart & Stats
$80.34
-$0.33(-0.58%)
At close: 4:00 PM EST
$80.34
-$0.33(-0.58%)
Day’s Range― - ―
52-Week Range$60.54 - $85.63
Previous CloseN/A
Volume628.04K
Average Volume (3M)3.87M
Market Cap
$57.38B
Enterprise Value$52.96B
Total Cash (Recent Filing)$2.14B
Total Debt (Recent Filing)$3.36B
Price to Earnings (P/E)50.2
Beta0.49
Next Earnings
Jul 30, 2026EPS Estimate
2.22Next Dividend Ex-DateN/A
Dividend Yield1.04%
Share Statistics
EPS (TTM)1.71
Shares Outstanding668,820,000
10 Day Avg. Volume5,169,605
30 Day Avg. Volume3,874,541
Financial Highlights & Ratios
PEG Ratio1.82
Price to Book (P/B)1.87
Price to Sales (P/S)2.59
P/FCF Ratio16.03
Enterprise Value/Market Cap0.92
Enterprise Value/Revenue2.96
Enterprise Value/Gross Profit6.32
Enterprise Value/Ebitda16.83
Forecast
1Y Price Target
$92.00Price Target Upside14.51% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering11
EPS Forecast (FY)3.74
Revenue Forecast (FY)$18.33B
Bulls Say, Bears Say
Bulls Say
Conservative Balance Sheet And Low LeverageA conservatively levered balance sheet with roughly $24B equity provides durable financial flexibility to fund R&D, separation costs, pension support and opportunistic buybacks without threatening investment-grade credit. That stability underpins long-term capital allocation and resilience to cyclical agricultural swings.
Strong Q1 Operating Execution And Reaffirmed GuidanceSustained margin expansion and a material EBITDA beat, coupled with management's reaffirmed full-year guidance, indicate underlying operational leverage and productivity gains. Durable margin improvement supports cash generation capacity, funds reinvestment in new products, and strengthens the standalone economics post-separation.
Decade-long Rimisoxafen Supply And Licensing CollaborationA multi-year co-exclusive agreement for rimisoxafen expands Corteva's herbicide portfolio with dual-mode tech addressing resistant weeds, enhancing product differentiation and long-term market share in corn/soy. The decade-long scope and $200M prepurchase lock in supply and accelerate commercial adoption across key geographies.
Bears Say
Free Cash Flow Decline And VolatilityA ~27% TTM decline in free cash flow and recent volatility weaken the predictability of self-funded investments and distributions. That variability complicates funding of separation-related costs, large discretionary pension payments, and ongoing R&D, increasing reliance on balance-sheet flexibility for multi-year strategic plans.
Large Restructuring And Exit Charges For Footprint OptimizationA sizable $750–$815M charge program with ~$400–$443M cash outlays through 2028 will absorb near-term cash, create execution risk, and may delay productivity gains. The multi-year disruption and regulatory consultation requirements raise the chance of higher costs or slower realization of targeted $300M run-rate savings by 2027.
Crop Protection Pricing Pressure And Modest Industry GrowthPersistently pressured crop protection pricing and only low-single-digit industry volume growth constrain margin sustainability for the CP segment. Combined with potential U.S. acreage shifts and farmers' value focus, structural headwinds may limit long-term revenue and require continued cost or product-mix offsets to preserve profitability.
Corteva News
CTVA FAQ
What was Corteva’s price range in the past 12 months?
Corteva lowest stock price was $60.53 and its highest was $85.63 in the past 12 months.
What is Corteva’s market cap?
Corteva’s market cap is $57.38B.
When is Corteva’s upcoming earnings report date?
Corteva’s upcoming earnings report date is Jul 30, 2026 which is in 26 days.
How were Corteva’s earnings last quarter?
Corteva released its earnings results on May 05, 2026. The company reported $1.5 earnings per share for the quarter, beating the consensus estimate of $1.174 by $0.326.
Is Corteva overvalued?
According to Wall Street analysts Corteva’s price is currently Undervalued.
Does Corteva pay dividends?
Corteva pays a Quarterly dividend of $0.18 which represents an annual dividend yield of 1.04%. See more information on Corteva dividends here
What is Corteva’s EPS estimate?
Corteva’s EPS estimate is 2.22.
How many shares outstanding does Corteva have?
Corteva has 668,820,000 shares outstanding.
What happened to Corteva’s price movement after its last earnings report?
Corteva reported an EPS of $1.5 in its last earnings report, beating expectations of $1.174. Following the earnings report the stock price went down -2.54%.
Which hedge fund is a major shareholder of Corteva?
Currently, no hedge funds are holding shares in CTVA
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
Corteva Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$92.00 (14.51% Upside)
$92.00 (14.51% Upside)
Blogger Sentiment
Bullish
CTVA Sentiment 70%
Sector Average ―
Sector Average ―
Hedge Fund Trend
Decreased
By 10.8M Shares
Last Quarter.
Last Quarter.
Crowd Wisdom
Very Positive
Last 7 Days ▲ 3.6%
Last 30 Days ▲ 2.7%
Last 30 Days ▲ 2.7%
News Sentiment
Very Bullish
Bullish news 100%
Bearish news 0%
Bearish news 0%
Technicals
SMA
Positive
20 days / 200 days
Momentum
12.50%
12-Months-Change
Fundamentals
Return on Equity
4.67%
Trailing 12-Months
Asset Growth
1.41%
Trailing 12-Months
Company Description
Corteva
Corteva, Inc. operates in the agriculture business. The company operates through two segments, Seed and Crop Protection. The Seed segment develops and supplies advanced germplasm and traits that produce optimum yield for farms. It offers trait technologies that enhance resistance to weather, disease, insects, and herbicides used to control weeds, as well as food and nutritional characteristics. This segment also provides digital solutions that assist farmer decision-making with a view to optimize product selection, and maximize yield and profitability. The Crop Protection segment offers products that protect against weeds, insects and other pests, and diseases, as well as enhances crop health above and below ground through nitrogen management and seed-applied technologies. This segment provides herbicides, insecticides, nitrogen stabilizers, and pasture and range management herbicides. It serves agricultural input industry. The company operates in the United States, Canada, Latin America, the Asia Pacific, Europe, the Middle East, and Africa. Corteva, Inc. was founded in 1802 and is headquartered in Indianapolis, Indiana.
CTVA Company Deck
CTVA Earnings Call
Q1 2026
0:00 / 0:00
Earnings Call Sentiment|Positive
The call conveyed a broadly positive tone: strong first-quarter execution (21% EBITDA growth, ~240 bps margin expansion), solid organic growth across Seed and Crop Protection, progress toward royalty-positive status and licensing momentum, and clear separation/capital allocation milestones. Headwinds include crop protection pricing pressure, higher SG&A and bad debt, one-time cash-flow hits (Bayer agreement and separation costs), and geopolitical/energy-related cost risk (a ~$40M H2 headwind). On balance, the positive operational and financial momentum and strategic milestones exceed the outlined near-term challenges.View all CTVA earnings summariesCTVA Revenue Breakdown
40.24% Corn
10.79% Soybean
3.70% Other oilseeds
2.15% Other
21.44% Herbicides
9.59% Insecticides
6.55% Fungicides
2.98% Biologicals
2.56% Other
CTVA Stock 12 Month Forecast
Average Price Target
$92.00
▲(14.51% Upside)
Technical Analysis
Ownership Overview
0.16% Insiders
30.72% Mutual Funds
0.05% Other Institutional Investors
44.39% Public Companies and
Individual Investors